Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jaguar Health, Inc. | Director | Stock option (right to buy) | 26.5K | Oct 8, 2024 | Direct | ||
Opy Acquisition Corp. I | Chief Executive Officer, Director | Common Stock | 0 | Oct 26, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JAGX | Jaguar Health, Inc. | Oct 8, 2024 | 1 | $0 | 4 | Oct 10, 2024 | Director |
JAGX | Jaguar Health, Inc. | Aug 14, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Director |
JAGX | Jaguar Health, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
JAGX | Jaguar Health, Inc. | May 18, 2022 | 2 | $0 | 4 | May 18, 2022 | Director |
JAGX | Jaguar Health, Inc. | Mar 28, 2022 | 1 | $0 | 4 | Mar 30, 2022 | Director |
OHAA | Opy Acquisition Corp. I | Oct 26, 2021 | 0 | $0 | 3 | Oct 27, 2021 | Chief Executive Officer, Director |
JAGX | Jaguar Health, Inc. | May 18, 2021 | 2 | $0 | 4 | May 20, 2021 | Director |